A Study of CC-90010 in Combination With Temozolomide With or Without Radiation Therapy in Participants With Newly Diagnosed Glioblastoma
Clinical trial NCT04324840 · TERMINATED
Trial details
- NCT number
- NCT04324840
- Sponsor
- Celgene
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-10
- Primary completion
- 2024-07-09
- Enrollment
- 184
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.